Atlas Trials

A Clinical Study on Neoadjuvant Treatment of Resectable Head and Neck Squamous Carcinoma With Immune-targeted Therapy and Lysogenic HSV Virus

Clinical trial NCT06741982 · RECRUITING

Trial details

NCT number
NCT06741982
Sponsor
West China Hospital
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
HNSCCLysogenic HSV VirusNeoadjuvant TherapyImmunotherapyTargeted Therapy
Start date
2024-12-15
Primary completion
2026-12-15
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.